Making a noteworthy insider sell on February 28, Isaac Zacharias, President at Shockwave Medical (NASDAQ:SWAV), is reported in the latest SEC filing.
What Happened: Zacharias opted to sell 4,000 shares of Shockwave Medical, according to a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The transaction's total worth stands at $1,041,440.
As of Wednesday morning, Shockwave Medical shares are down by 0.0%, currently priced at $263.47.
Delving into Shockwave Medical's Background
Shockwave Medical Inc is a medical device company focused on developing and commercializing novel technologies that transform the care of patients with cardiovascular disease. It establishes a new standard of care for the treatment of calcified cardiovascular disease ("atherosclerosis") through differentiated and proprietary local delivery of sonic pressure waves, which refer to as intravascular lithotripsy ("IVL"). Its IVL technology is a minimally invasive, easy-to-use, and safe way to improve outcomes for patients with calcified cardiovascular disease also IVL catheters enables delivery of IVL therapy to diseased vasculature throughout the body for calcium modification.
Unraveling the Financial Story of Shockwave Medical
Revenue Growth: Shockwave Medical's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth ...